Free Subscription

  • Access daily briefings and unlimited news articles

Premium

Only $34.95 per year
  • Quarterly magazine and digital
  • Indepth executive interviews
  • Unlimited news and insights
  • Expert opinion and analysis

Voltaren Osteo Gel

Voltaren Osteo Gel Archives

GSK and Novartis face penalties for misleading consumers on Voltaren products

GSK and Novartis admit that they breached Australian Consumer Law in marketing of Voltaren.

ACCC claims ‘misleading representations’ of Voltaren products

"The alleged conduct is particularly concerning."